BBOT
Price
$8.84
Change
-$0.82 (-8.49%)
Updated
Aug 22 closing price
Capitalization
700.1M
10 days until earnings call
VKTX
Price
$26.00
Change
+$0.34 (+1.33%)
Updated
Aug 22 closing price
Capitalization
2.92B
58 days until earnings call
Interact to see
Advertisement

BBOT vs VKTX

Header iconBBOT vs VKTX Comparison
Open Charts BBOT vs VKTXBanner chart's image
BridgeBio Oncology Therapeutics
Price$8.84
Change-$0.82 (-8.49%)
Volume$169.1K
Capitalization700.1M
Viking Therapeutics
Price$26.00
Change+$0.34 (+1.33%)
Volume$10.59M
Capitalization2.92B
BBOT vs VKTX Comparison Chart in %
Loading...
BBOT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BBOT vs. VKTX commentary
Aug 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BBOT is a Hold and VKTX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 25, 2025
Stock price -- (BBOT: $8.84 vs. VKTX: $26.00)
Brand notoriety: BBOT and VKTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BBOT: 175% vs. VKTX: 169%
Market capitalization -- BBOT: $700.1M vs. VKTX: $2.92B
BBOT [@Biotechnology] is valued at $700.1M. VKTX’s [@Biotechnology] market capitalization is $2.92B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.31B to $0. The average market capitalization across the [@Biotechnology] industry is $1.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BBOT’s FA Score shows that 1 FA rating(s) are green whileVKTX’s FA Score has 0 green FA rating(s).

  • BBOT’s FA Score: 1 green, 4 red.
  • VKTX’s FA Score: 0 green, 5 red.
According to our system of comparison, both BBOT and VKTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BBOT’s TA Score shows that 2 TA indicator(s) are bullish while VKTX’s TA Score has 5 bullish TA indicator(s).

  • BBOT’s TA Score: 2 bullish, 3 bearish.
  • VKTX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, VKTX is a better buy in the short-term than BBOT.

Price Growth

BBOT (@Biotechnology) experienced а -17.00% price change this week, while VKTX (@Biotechnology) price change was -35.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.57%. For the same industry, the average monthly price growth was +18.06%, and the average quarterly price growth was +26.94%.

Reported Earning Dates

BBOT is expected to report earnings on Sep 03, 2025.

VKTX is expected to report earnings on Oct 22, 2025.

Industries' Descriptions

@Biotechnology (+2.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VKTX($2.92B) has a higher market cap than BBOT($700M). BBOT YTD gains are higher at: -15.810 vs. VKTX (-35.388).
BBOTVKTXBBOT / VKTX
Capitalization700M2.92B24%
EBITDAN/A-212.42M-
Gain YTD-15.810-35.38845%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A808M-
Total DebtN/A878K-
FUNDAMENTALS RATINGS
VKTX: Fundamental Ratings
VKTX
OUTLOOK RATING
1..100
24
VALUATION
overvalued / fair valued / undervalued
1..100
37
Fair valued
PROFIT vs RISK RATING
1..100
79
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
88
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BBOTVKTX
RSI
ODDS (%)
Bearish Trend 3 days ago
25%
Bullish Trend 3 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
33%
Bullish Trend 3 days ago
82%
Momentum
ODDS (%)
Bearish Trend 3 days ago
6%
Bearish Trend 3 days ago
85%
MACD
ODDS (%)
N/A
Bearish Trend 3 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
4%
Bearish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
10%
Bearish Trend 3 days ago
87%
Advances
ODDS (%)
Bullish Trend 7 days ago
16%
Bullish Trend 12 days ago
82%
Declines
ODDS (%)
N/A
Bearish Trend 10 days ago
85%
BollingerBands
ODDS (%)
N/A
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 3 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
BBOT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYMDX137.325.42
+4.11%
Rydex Mid-Cap 1.5x Strategy H
PFSZX26.460.58
+2.24%
PGIM Jennison Financial Services Z
PIUCX24.000.41
+1.74%
Federated Hermes International Equity C
JNVMX19.110.27
+1.43%
JPMorgan Developed International ValueR6
OEGIX35.740.40
+1.13%
Invesco Discovery Mid Cap Growth R6

BBOT and

Correlation & Price change

A.I.dvisor tells us that BBOT and VKTX have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BBOT and VKTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BBOT
1D Price
Change %
BBOT100%
-8.49%
VKTX - BBOT
32%
Poorly correlated
+1.33%
SNGX - BBOT
28%
Poorly correlated
+0.60%
COCP - BBOT
25%
Poorly correlated
+3.95%
PRTC - BBOT
22%
Poorly correlated
+3.26%
NERV - BBOT
22%
Poorly correlated
+0.83%
More

VKTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VKTX has been loosely correlated with SYRE. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if VKTX jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VKTX
1D Price
Change %
VKTX100%
+1.33%
SYRE - VKTX
42%
Loosely correlated
+3.58%
GPCR - VKTX
41%
Loosely correlated
+1.24%
XNCR - VKTX
41%
Loosely correlated
+13.04%
XENE - VKTX
40%
Loosely correlated
+1.73%
RGNX - VKTX
39%
Loosely correlated
+11.10%
More